Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thyroid Neoplasms × Thyrotropin Alfa × Clear all

Phase

Status

Completed 7 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Differentiated Thyroid Cancer 2 Thyroid Neoplasms 1 Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1

Interventions

Thyroidectomy 4 trametinib 3 dabrafenib 3 Iodine-131 3 apatinib 2 anlotinib 2 Surgical Procedures, Operative 2 Biopsy, Large-Core Needle 2 toripalimab 1 tislelizumab 1 surufatinib 1 regorafenib 1 penpulimab 1 pembrolizumab 1 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 famitinib 1 camrelizumab 1 Ultrasonography 1 Thyroxine 1 Thyrotropin Alfa 1 Sunitinib 1 Second Harmonic Generation Microscopy 1 Routinely Collected Health Data 1 Rosiglitazone 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00435851 2007-02-19

Estimabl

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Unknown

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡